44 related articles for article (PubMed ID: 32770107)
1. PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
Chanda A; Ikeuchi Y; Karve K; Sarkar A; Chandhoke AS; Deng L; Bonni A; Bonni S
Cell Death Differ; 2021 Jan; 28(1):267-282. PubMed ID: 32770107
[TBL] [Abstract][Full Text] [Related]
2. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.
Sugiokto FG; Saiada F; Zhang K; Li R
mBio; 2024 Feb; 15(2):e0316823. PubMed ID: 38236021
[TBL] [Abstract][Full Text] [Related]
3. PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington's disease.
Morozko EL; Smith-Geater C; Monteys AM; Pradhan S; Lim RG; Langfelder P; Kachemov M; Kulkarni JA; Zaifman J; Hill A; Stocksdale JT; Cullis PR; Wu J; Ochaba J; Miramontes R; Chakraborty A; Hazra TK; Lau A; St-Cyr S; Orellana I; Kopan L; Wang KQ; Yeung S; Leavitt BR; Reidling JC; Yang XW; Steffan JS; Davidson BL; Sarkar PS; Thompson LM
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468657
[TBL] [Abstract][Full Text] [Related]
4. Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1.
Suda N; Shibata H; Kurihara I; Ikeda Y; Kobayashi S; Yokota K; Murai-Takeda A; Nakagawa K; Oya M; Murai M; Rainey WE; Saruta T; Itoh H
Endocrinology; 2011 Jun; 152(6):2266-77. PubMed ID: 21467194
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics integration identifies cell-state-specific repression by PBRM1-PIAS1 cooperation.
Ho PJ; Kweon J; Blumensaadt LA; Neely AE; Kalika E; Leon DB; Oh S; Stringer CWP; Lloyd SM; Ren Z; Bao X
Cell Genom; 2024 Jan; 4(1):100471. PubMed ID: 38190100
[TBL] [Abstract][Full Text] [Related]
6. Super-resolution study of PIAS SUMO E3-ligases in hippocampal and cortical neurons.
Conz A; Musi CA; Russo L; Borsello T; Colnaghi L
Eur J Histochem; 2021 Aug; 65(s1):. PubMed ID: 34459572
[TBL] [Abstract][Full Text] [Related]
7. SUMOylation of SMAD4 by PIAS1 in Conjunction with Vimentin Upregulation Promotes Migration Potential in Non-Small Cell Lung Cancer.
Wu C; Zhu X; Dai Q; Chu Z; Yang S; Dong Z
Front Biosci (Landmark Ed); 2023 Aug; 28(8):192. PubMed ID: 37664931
[TBL] [Abstract][Full Text] [Related]
8. SLX4IP promotes RAP1 SUMOylation by PIAS1 to coordinate telomere maintenance through NF-κB and Notch signaling.
Robinson NJ; Miyagi M; Scarborough JA; Scott JG; Taylor DJ; Schiemann WP
Sci Signal; 2021 Jun; 14(689):. PubMed ID: 34187905
[TBL] [Abstract][Full Text] [Related]
9. Novel role and mechanism of protein inhibitor of activated STAT1 in spatial learning.
Tai DJ; Hsu WL; Liu YC; Ma YL; Lee EH
EMBO J; 2011 Jan; 30(1):205-20. PubMed ID: 21102409
[TBL] [Abstract][Full Text] [Related]
10. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.
Sugiokto FG; Saiada F; Zhang K; Li R
bioRxiv; 2023 Aug; ():. PubMed ID: 37609256
[TBL] [Abstract][Full Text] [Related]
11. A novel role for the SUMO E3 ligase PIAS1 in cancer metastasis.
Dadakhujaev S; Salazar-Arcila C; Netherton SJ; Chandhoke AS; Singla AK; Jirik FR; Bonni S
Oncoscience; 2014; 1(3):229-40. PubMed ID: 25594015
[TBL] [Abstract][Full Text] [Related]
12. Targeting SUMOylation in cancer.
Du L; Liu W; Rosen ST
Curr Opin Oncol; 2021 Sep; 33(5):520-525. PubMed ID: 34280172
[TBL] [Abstract][Full Text] [Related]
13. PIAS1 impedes vascular endothelial injury and atherosclerotic plaque formation in diabetes by blocking the RUNX3/TSP-1 axis.
Jin Q; Zhao T; Lin L; Yao X; Teng Y; Zhang D; Jin Y; Yang M
Hum Cell; 2023 Nov; 36(6):1915-1927. PubMed ID: 37584829
[TBL] [Abstract][Full Text] [Related]
14. Correction: PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
Chanda A; Ikeuchi Y; Karve K; Sarkar A; Chandhoke AS; Deng L; Bonni A; Bonni S
Cell Death Differ; 2021 May; 28(5):1753. PubMed ID: 32811972
[No Abstract] [Full Text] [Related]
15. SENP3 loss promotes M2 macrophage polarization and breast cancer progression.
Xiao M; Bian Q; Lao Y; Yi J; Sun X; Sun X; Yang J
Mol Oncol; 2022 Feb; 16(4):1026-1044. PubMed ID: 33932085
[TBL] [Abstract][Full Text] [Related]
16. PIAS family in cancer: from basic mechanisms to clinical applications.
Li X; Rasul A; Sharif F; Hassan M
Front Oncol; 2024; 14():1376633. PubMed ID: 38590645
[TBL] [Abstract][Full Text] [Related]
17. The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications.
Gu Y; Fang Y; Wu X; Xu T; Hu T; Xu Y; Ma P; Wang Q; Shu Y
Exp Hematol Oncol; 2023 Jul; 12(1):58. PubMed ID: 37415251
[TBL] [Abstract][Full Text] [Related]
18. Sumoylated SnoN interacts with HDAC1 and p300/CBP to regulate EMT-associated phenotypes in mammary organoids.
Chanda A; Sarkar A; Deng L; Bonni A; Bonni S
Cell Death Dis; 2023 Jul; 14(7):405. PubMed ID: 37414747
[TBL] [Abstract][Full Text] [Related]
19. SUMOylation of Rho-associated protein kinase 2 induces goblet cell metaplasia in allergic airways.
Tan D; Lu M; Cai Y; Qi W; Wu F; Bao H; Qv M; He Q; Xu Y; Wang X; Shen T; Luo J; He Y; Wu J; Tang L; Barkat MQ; Xu C; Wu X
Nat Commun; 2023 Jul; 14(1):3887. PubMed ID: 37393345
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
